Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Veterinary Clinical Trials Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The veterinary clinical trials market has experienced robust expansion lately, projected to increase from $4.85 billion in 2025 to $5.32 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.7%. This recent surge in growth is underpinned by several key factors, including advancements in veterinary pharmaceutical research, a notable rise in pet ownership, escalating demand for scientifically validated veterinary therapies, the broadening scope of academic zoological research initiatives, and the enhancement of regulatory structures governing animal studies.
The domain of veterinary clinical trials is poised for considerable expansion in the coming years, with projections indicating a market valuation of $7.61 billion by 2030, driven by a compound annual growth rate of 9.4%. This anticipated surge is fueled by several key factors: augmented financial commitment towards the creation of veterinary pharmaceuticals, a burgeoning embrace of personalized medicinal approaches for animal healthcare, a widening scope of Contract Research Organization (CRO) participation in veterinary studies, heightened attention on long-term health conditions and cancer treatments in animals, and a greater utilization of real-world data within the animal health sector. Furthermore, prevailing trends expected to shape the forecast period include a greater uptake of digital systems for managing trials, an increased prevalence of studies leveraging genomics and biomarkers, a growing emphasis on research concerning companion animals, an expansion in the number of veterinary trials conducted across multiple centers, and a more pronounced focus on ensuring data reliability and adherence to regulatory standards.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20683&type=smp
Veterinary Clinical Trials Market Growth Drivers And Industry Catalysts
The increasing prevalence of pet ownership is poised to be a significant driver for the veterinary clinical trials market’s expansion. This trend, wherein individuals choose to have and care for animals as domestic companions, is influenced by a multitude of factors such as the fundamental human need for companionship, the recognized advantages of pet-assisted therapy, and a broader understanding of how animals positively affect both mental and physical health. Veterinary clinical trials, in turn, benefit immensely from this heightened pet ownership by facilitating wider access to advanced therapeutic options for animal companions and by pushing the frontiers of veterinary medicine, ultimately leading to improved health prognoses for these animals. Furthermore, these trials are instrumental in the creation of more secure and efficacious treatment modalities. As an illustration, data from a US-based pet food producer, as reported by Petfood Industry in June 2025, indicated that around 68 million dogs resided in American homes during the most recent survey period, a notable increase from the 65.1 million recorded in the 2023–2024 study, thereby underscoring how the growing ranks of pet owners are fueling the momentum within the veterinary clinical trials sector.
Veterinary Clinical Trials Market Segmentation Trends And Revenue Drivers
The veterinary clinical trials market covered in this report is segmented –
1) By Animal: Livestock Animal, Companion Animal, Other Animals
2) By Indications: Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, Other Indications
3) By Intervention: Medicines, Medical Devices, Other Interventions
4) By End-Users: Academics And Research Centers, Pharmaceutical And Biopharmaceutical Companies, Other End-Users
Subsegments:
1) By Livestock Animal: Cattle, Sheep, Goats, Swine, Poultry
2) By Companion Animal: Dogs, Cats, Horses, Rabbits, Ferrets
3) By Other Animals: Wildlife, Exotic Pets, Laboratory Animals, Aquatic Animals
#Veterinary Clinical Trials Market Trends Influencing Long-Term Demand
In the competitive veterinary clinical trials landscape, leading entities are dedicating their efforts toward pioneering new anti-aging pharmaceuticals aimed at prolonging the lives of companion animals and elevating their general well-being. These cutting-edge anti-aging medications are formulated to decelerate or even reverse the effects of aging, thereby fostering improved health and vigor in older pets. As an illustration, Loyal, a veterinary innovator based in the United States, initiated a clinical investigation in February 2024 for a groundbreaking anti-aging compound, LOY-002, with the express purpose of extending the healthy years of senior canines. This new formulation is engineered to optimize canine metabolic function, addressing the physiological changes associated with aging that often precipitate a cascade of health complications. The palatable chewable, intended for senior dogs of various sizes, excluding the very smallest breeds, is presently undergoing evaluation within the STAY study, a comprehensive trial projected to involve upwards of a thousand dogs aged ten and above, conducted across more than fifty veterinary practices nationwide. The central goal of LOY-002 is to bolster metabolic efficiency, potentially mitigating the onset of age-related ailments and augmenting the overall quality of life for aging dogs.
Veterinary Clinical Trials Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the veterinary clinical trials market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Hill’s Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., Veterinary Research Management
Access The Complete Veterinary Clinical Trials Market Report:
https://www.thebusinessresearchcompany.com/report/veterinary-clinical-trials-global-market-report
Veterinary Clinical Trials Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the veterinary clinical trials market in 2025. The regions covered in the veterinary clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
